Peter M. Henson

Peter M. Henson, MD, PhD, BVMS

  • Professor
  • Department of Pediatrics
  • Integrated Department of Immunology

Profile

Research Areas

  • Basic Immunology
  • Cellular and Molecular Biology
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Infectious Diseases
  • Inflammation
  • Inflammatory Lung Disease
  • Interstitial Lung Disease (ILD)

Programs & Services

Gender:
Male

Education & Training

Education

1963
University of Edinburgh, BVM&S
1964
University of Edinburgh, BSc with Honors, Microbiology
1967
University of Cambridge, PhD

Teaching or Professional Positions

Associate Director, Pulmonary Fellowship Program, University of Colorado

Industry Relationships & Collaborations

National Jewish Health physicians and scientists may collaborate with pharmaceutical or other industries to develop medical and scientific breakthroughs or to provide education on trends in quality medical practice and outcomes to physicians and health professionals around the country. National Jewish Health maintains a strict conflict of interest policy to ensure that all potential conflicts are clearly visible and that management plans are put in place in order to further innovation and education while ensuring the protection of our patients and the integrity of our research. National Jewish Health publicly discloses any payment to our physicians or scientists. View this faculty member’s industry relationships and collaborations.

Affiliations with the University of Colorado Denver

Professor of Immunology, Medicine and Pharmacology

Awards & Recognition

2011: Distinguished Professor, University of Colorado
2005: ATS Burns Amberson Lectureship
2002: Honorary Doctorate of Medicine, University of Edinburgh
1980: AAP Park Davis Award

Publications

Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL and Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol. 148(7):2207-2216, 1992.

Gardai SH, Xiao Y-Q, Dickinson M, Nick J, Voelker D, Greene K, Henson P. By binding SIRP? or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell. 115:13-23, 2003.

Gardai S.J, McPhillips KA, Frasch SC, Janssen W.J, Starefeldt A, Murphy-Ullrich JE, Bratton DL, Oldenborg PA, Michalak M, Henson PM. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123:321-334, 2005.

Desch AN, Randolph GJ, Murphy K, Gautier EL, Kedl RM, Lahoud MH, Caminschi I, Shortman K, Henson PM, Jakubzick CV. CD103+ pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen. J Exp Med 208(9): 1789-97, 2011

Cole C, Thomas S, Filak H, Henson PM, Lenz LL, Nitric oxide increases susceptibility of toll-like receptor-activated macrophages to spreading Listeria monocytogenes. Immunity, May 25; 36(5):807-20. 2012

More Publications by This Author

Link to Faculty Publications

Link to PubMed for more papers

Office Information

Doctor's Contact Information

  • Office: 303.398.1380
  • Fax: 303.398.1381
  • Email: hensonp@njhealth.org

Locations

  • Main Campus
    1400 Jackson St.
    Denver, CO 80206
    Main: 877.225.5654

Newsroom


In the Newsroom, you can find National Jewish Health press releases, newsletters, annual reports and media contacts. Learn more.